FDA Inspection 947439 — Shore Institute For Reproductive Medicine, P.C.
The FDA completed an inspection of Shore Institute For Reproductive Medicine, P.C. on November 4, 2015 in Lakewood, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 4, 2015
- Fiscal Year
- 2016
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Lakewood, NJ (United States)